Sunshine Biopharma (NASDAQ:SBFM) Issues Quarterly Earnings Results

Sunshine Biopharma (NASDAQ:SBFM) released its earnings results on Tuesday. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of $9.00 by ($9.94), Zacks reports. Sunshine Biopharma had a negative net margin of 12.07% and a negative return on equity of 16.09%. The company had revenue of $8.44 million for the quarter.

Sunshine Biopharma Trading Down 6.3 %

Sunshine Biopharma stock traded down $0.18 during midday trading on Wednesday, hitting $2.68. The stock had a trading volume of 183,055 shares, compared to its average volume of 127,613. Sunshine Biopharma has a 52-week low of $2.42 and a 52-week high of $637.20. The firm’s fifty day moving average is $2.96 and its two-hundred day moving average is $1.64. The company has a market capitalization of $3.27 million, a PE ratio of -0.01 and a beta of 1.38.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.